STANDARDIZATION OF INCLUSION COMPLEX OF DISULFIRAM WITH HYDROXYPROPYL-β-CYCLODEXTRIN FOR USE AS PHARMACEUTICAL SUBSTANCES
The State Pharmacopoeia XIII sets out the main principles of quality of pharmaceutical substances listed parametrs that should be included in the regulatory documents, given the characteristics of these indicators and recommendations for their regulation. Input quality control performance and valuat...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2019-01-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/91 |
| id |
doaj-fd675ec76f50458fa1f149d2376168f5 |
|---|---|
| record_format |
Article |
| spelling |
doaj-fd675ec76f50458fa1f149d2376168f52021-07-28T13:06:53ZrusLLC Center of Pharmaceutical Analytics (LLC «CPHA»)Разработка и регистрация лекарственных средств2305-20662658-50492019-01-010210410791STANDARDIZATION OF INCLUSION COMPLEX OF DISULFIRAM WITH HYDROXYPROPYL-β-CYCLODEXTRIN FOR USE AS PHARMACEUTICAL SUBSTANCESS. A. Kedik0A. V. Panov1V. S. Tyukova2Moscow Technological University (MITHT); CJSC Institute of Pharmaceutical TechnologiesMoscow Technological University (MITHT); CJSC Institute of Pharmaceutical TechnologiesMoscow Technological University (MITHT); CJSC Institute of Pharmaceutical TechnologiesThe State Pharmacopoeia XIII sets out the main principles of quality of pharmaceutical substances listed parametrs that should be included in the regulatory documents, given the characteristics of these indicators and recommendations for their regulation. Input quality control performance and valuation limits must comply with the appointment of the pharmaceutical substance. This paper presents the key indicators that can be used to standardize the inclusion complex of disulfiram with hydroxypropyl-β-cyclodextrin for later use as a pharmaceutical substance.https://www.pharmjournal.ru/jour/article/view/91standardizationquality controlpharmaceutical substancesinclusion complexdisulfiramhydroxypropyl-β-cyclodextrin |
| collection |
DOAJ |
| language |
Russian |
| format |
Article |
| sources |
DOAJ |
| author |
S. A. Kedik A. V. Panov V. S. Tyukova |
| spellingShingle |
S. A. Kedik A. V. Panov V. S. Tyukova STANDARDIZATION OF INCLUSION COMPLEX OF DISULFIRAM WITH HYDROXYPROPYL-β-CYCLODEXTRIN FOR USE AS PHARMACEUTICAL SUBSTANCES Разработка и регистрация лекарственных средств standardization quality control pharmaceutical substances inclusion complex disulfiram hydroxypropyl-β-cyclodextrin |
| author_facet |
S. A. Kedik A. V. Panov V. S. Tyukova |
| author_sort |
S. A. Kedik |
| title |
STANDARDIZATION OF INCLUSION COMPLEX OF DISULFIRAM WITH HYDROXYPROPYL-β-CYCLODEXTRIN FOR USE AS PHARMACEUTICAL SUBSTANCES |
| title_short |
STANDARDIZATION OF INCLUSION COMPLEX OF DISULFIRAM WITH HYDROXYPROPYL-β-CYCLODEXTRIN FOR USE AS PHARMACEUTICAL SUBSTANCES |
| title_full |
STANDARDIZATION OF INCLUSION COMPLEX OF DISULFIRAM WITH HYDROXYPROPYL-β-CYCLODEXTRIN FOR USE AS PHARMACEUTICAL SUBSTANCES |
| title_fullStr |
STANDARDIZATION OF INCLUSION COMPLEX OF DISULFIRAM WITH HYDROXYPROPYL-β-CYCLODEXTRIN FOR USE AS PHARMACEUTICAL SUBSTANCES |
| title_full_unstemmed |
STANDARDIZATION OF INCLUSION COMPLEX OF DISULFIRAM WITH HYDROXYPROPYL-β-CYCLODEXTRIN FOR USE AS PHARMACEUTICAL SUBSTANCES |
| title_sort |
standardization of inclusion complex of disulfiram with hydroxypropyl-β-cyclodextrin for use as pharmaceutical substances |
| publisher |
LLC Center of Pharmaceutical Analytics (LLC «CPHA») |
| series |
Разработка и регистрация лекарственных средств |
| issn |
2305-2066 2658-5049 |
| publishDate |
2019-01-01 |
| description |
The State Pharmacopoeia XIII sets out the main principles of quality of pharmaceutical substances listed parametrs that should be included in the regulatory documents, given the characteristics of these indicators and recommendations for their regulation. Input quality control performance and valuation limits must comply with the appointment of the pharmaceutical substance. This paper presents the key indicators that can be used to standardize the inclusion complex of disulfiram with hydroxypropyl-β-cyclodextrin for later use as a pharmaceutical substance. |
| topic |
standardization quality control pharmaceutical substances inclusion complex disulfiram hydroxypropyl-β-cyclodextrin |
| url |
https://www.pharmjournal.ru/jour/article/view/91 |
| work_keys_str_mv |
AT sakedik standardizationofinclusioncomplexofdisulfiramwithhydroxypropylbcyclodextrinforuseaspharmaceuticalsubstances AT avpanov standardizationofinclusioncomplexofdisulfiramwithhydroxypropylbcyclodextrinforuseaspharmaceuticalsubstances AT vstyukova standardizationofinclusioncomplexofdisulfiramwithhydroxypropylbcyclodextrinforuseaspharmaceuticalsubstances |
| _version_ |
1721276927232180224 |